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Summary.-The clinical use of the radiosensitizer misonidazole may be limited by
the incidence of peripheral neuropathy reported following total doses in excess of
18 g. A recent report noted a decrease in nerve conduction velocity following a single
i.p. injection of 1 mg/g misonidazole to mice. The present study was unable to confirm
such changes when nerve conduction velocity measurements were made in situ or
in isolated sural, tibial or median nerves of mice. Other electrophysiological para-
meters such as threshold, strength-duration curves, refractory time or the ability
to carry high-frequency stimulation also showed no change. However, it was noted
that a single administration of the radio-sensitizer produced a marked decrease in
body temperature which persisted for at least 2 h after the elimination of the drug
from the blood serum. The physiological response of reduction of body temperature
may protect the mouse against the effect ofthe toxic chemical species involved in the
induction of neurotoxicity.
THE NITROIMIDAZOLE misonidazole (Ro-
07-0582) has been found to increase the
sensitivity of hypoxic cells to the effects
ofionizing radiation in vitro and in animal
tumours (reviewed by Fowler et al., 1976).
Considerable interest has developed to
assess the use of misonidazole (MIS) as a
potential adjuvant to radiation therapy
in human solid tumours. Preliminary
studies with MIS in normal human volun-
teers did not indicate any toxic effects of
the drug at the dose levels employed
(Foster et al., 1975). However, subsequent
studies on cancer patients reported contra-
indicative side-effects such as convulsions
and peripheral neuropathy ranging from
a sensory neuropathy to a severe poly-
neuropathy (Urtasun et al., 1977, 1978;
Dische et al., 1977; Kogelnik et al., 1978).
Urtasun et al. (1978) report that the neuro-
pathy occurred more frequently and with
greater severity when the drug was admin-
istered 3 x weekly and when patients
received total doses in excess of 18 g
(approximately 11 g/m2). Electron-micro-
scopic data suggested residual axonal
degeneration accompanied by some de-
myelination (Urtasun et al., 1978). There
is some evidence that the incidence of
peripheral neuropathy may be related to
the half-life and the serum plateau level
of the drug (Saunders et al., 1978). It has
recently been reported that nerve conduc-
tion velocity of mice was altered by the
administration ofMIS and that thisreduc-
tion could be correlated to the uptake and
excretion profile of the drug in the blood
serum (Hirst et al., 1978). We wish to
report our experience with a similar study
on nerve-conduction velocity in mice.
MATERIALS AND METHODS
Nitroimidazole extraction method and
spectrophotometric assay.-The procedure
was a modification of that described by
Searle & Willson (1976). Blood samples
(0.3-0.6 ml) were removed under ether
anaesthesia by cardiac puncture and centri-
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fuged (25,000 g average) in an Eppendorf
microfuge (Model 5412, Brinckman Instru-
ments, Westbury, N.Y.) for 2 min at room
temperature. Serum samples (0-1 ml) were
added to 04 ml phosphate-buffered saline
(pH 7.4), extracted into 4-5 ml ethyl acetate
in 10x 75mm glass-stoppered tubes, vigor-
ously shaken on a "vortexmixer" for 2 min
and centrifuged (2500 g average) for 8 min.
The absorbance at 316 mm of a 3ml aliquot
ofthe upper ethyl acetate layer was measured
against an appropriate serum blank in a
Gilford Model250Spectrophotometer (Gilford
Instrument Labs, Inc., Oberlin, Ohio). The
extraction efficiency was 95-0A 2.5% with a
lower limit of drug detection of -2 ,ug/ml
(0-01 mM).
Nerveisolationprocedure.-Thesciaticnerve
was exposed by a dorsal approach and
ligated as close to the iliac orbit as possible.
The sural nerve was traced across the belly of
the gastrocnemius muscle and a second
ligaturetied inthe area ofthe Achilles tendon.
By manipulation of the threads, the nerve
was gently lifted, isolated, severed, and
removed with the aid of small spring scissors
and placed in a 55mm Petri dish which con-
tained -5 ml ofMcEwan's solution (McEwan,
1956). The sciatic nerve of the opposite limb
was similarly exposed and tied. The Achilles
tendon was grasped with forceps, severed,
peeled back, and removed to expose the
underlying tibial nerve. A second ligature
was passed distally, the nerve removed and
placed in the Petri dish. With a ventral
approach, the median nerve was then ex-
posed, isolated, tied as distal as possible and
also placed in the Petri dish. Nerve lengths of
12-15 mm were routinely obtained.
The isolated nerves were taken in order,
briefly blotted and suspended from glass-
insulated, stainless-steel wire "J" electrodes
held by micromanipulators (Brinkman In-
struments, N.Y. or Scientific Prototype,
N.Y.). Tension on the nerve was adjusted to
the point at which the threads began to slide
across the electrodes. Measurement of the
length of the nerve under study with this
technique is a potential source of error in the
computation of conduction velocity. How-
ever, we were careful to standardise our
method and the resultant measurements
compared well with those values obtained in
situ. The nerve and electrodes were immersed
in a mineral-oil bath (CVS Extra Heavy
Mineral Oil) that consisted of a thermostatic
jacket (Radiometer Corp., Denmark, Type
V526) connected to a temperature-controlled
water circulation bath (Haake Inst., Ger-
many, Type FE). The oil bath contained a
magnetic stirrer. The temperature of the oil
was monitored by a Yellow Springs Tele-
thermometer equipped with a 511 probe that
was calibrated against a laboratory mercury
thermometer. Temperature was maintained
at 36-8±0 50C.
Recording procedures.-The preparation
was stimulated and recordings obtained in
conventional fashion by using a Grass S4
stimulator (Grass Co., Quincy, MA), a Grass
SIU 4 isolation unit, and a Grass P511 pre-
amplifier with filters set at 0a1 Hz and 30 kHz.
A Tektronics 564B storage oscilloscope
equipped with a Type 3A3 amplifier and a
500 kHz band pass was used. The oscilloscope
was routinely calibrated by the built-in
calibration unit. Conduction-velocity meas-
urements were made on action potentials
evoked by a stimulus intensity of 11 V as
measured on the output side of the SIU.
Permanent records were obtained by polaroid
photography of the oscilloscope screen.
Calculations of velocity were made directly
from the photographs and were based on the
image of the oscilloscope graticule, the re-
corded time-base setting and the ms delay
between the onset of the stimulus artefact
and the highest point of the observed wave
form. This method of calculation, with our
equipment, proved to be more suitable than
extrapolation to a base line, since most ofthe
peaks we saw were well defined. Our estimate
ofthe error contributed by this to the overall
estimate of the conduction velocity is 5%.
The distance between the stimulating cathode
andthe firstrecording electrode was measured
with a pair of screw-adjustable dividers.
Threshold values and strength-duration
curves were recorded. The highest frequency
of stimulation that could be carried by the
nerve, and the refractory time, as measured
by the minimum time between 2 successive
stimulation pulses which would elicit a
second action potential, were routinely deter-
mined for each nerve tested.
In situ conduction velocity measurements.-
In situ measurements used a 3-prong glass-
insulated stainless-steel "J" configuration
electrode with the cathodes separated by a
distance of 6-5 mm. Stimulation was applied
first to one cathode and then the other; the
superimposed oscilloscope traces allowed the
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measurement of conduction delay, and con-
duction velocity was calculated on the
difference in stimulation distance. Muscle-
action potentials were recorded with the fine-
wire electrodes described by Basmajian &
Stecko (1962).
Experimental animals.-Female BALB/
cKa mice weighing 18-22 g were purchased
from Bio-Breeding Laboratories, Ottawa,
Ontario, Canada. Male CBA/J mice (23-25 g)
were obtained from Jackson Labs, Bar Har-
bor, Maine.
Drug preparation and source.-Misonid-
azole (NSC #261037, MIS) was dissolved in
phosphate-buffered saline (PBS) adjusted to
a pH of 7-4 at a concentration of 20 mg/ml
and injected i.p. at a dose of 1 mg/g. The drug
was supplied by the Drug Synthesis and
Chemistry Branch, Division of Cancer Treat-
ment, National Cancer Institute, Bethesda,
Maryland.
Drug serum profile.-Groups of 6 BALB/
cKa mice were injected i.p. with 1 mg/g body
wt MIS in PBS at ambient temperature
(22°C) and the serum drug levels determined
by the UV spectrophotometric assay de-
scribed above at 5, 10, 15, and 30 min and 1,
2, 4, 8, 12, and 24 h after injection.
Experimental protocols.-In the 1st experi-
ment, groups of 4-5 BALB/cKa mice were
injected with 1 mg/g body wt MIS in
PBS at 22°C and taken for electrophysio-
logical testing at 1, 2, 4, and 6 h later. The
animals were anaesthetized with 100 mg/kg
of sodium pentobarbital (V-Pento, A. J.
Buck & Son, Cockeysville, MD) by i.p. injec-
tion. No lethality was observed in these mice
from the combined effects of MIS and pento-
barbital.
In the 2nd experiment, CBA/J mice weigh-
ing 20-23 g were used for body-temperature
measurements. The animals were randomly
separated into 3 groups of 5. Group 1 re-
ceived 100 mg/kg of pentobarbital i.p. Group
2 received the anaesthetic followed by 1 mg/g
MIS within 5 min. Group 3 received the
anaesthetic followed by an equivalent volume
of PBS within the same interval. Rectal
temperatures ofeach animal were obtained by
inserting the 511 probe to a depth of 1-0-1-5
cm. Temperature was monitored for up to 7 h.
In the 3rd experiment, similar mice re-
ceived 1 mg/g of MIS i.p. Rectal tempera-
tures of 10 mice were monitored for 11 h, at
which time 5 animals were anaesthetized
with Penthrane (Abbott Labs, Chicago, Ill.)
and conduction velocity ofthe sural and tibial
nerves measured. The temperatures of the
remaining 5 animals continued to be moni-
tored, and their nerve conduction velocity
was analysed after 4 h.
For the 4th experiment, a group of 5 male
CBA/J mice was injected with 1 ml PBS/20 g
body wt (22°C) and in situ measurements of
gastrocnemius muscle response made after
serial stimulation at 7-8 V under Penthrane
anaesthesia.
RESULTS
A typical recorded action potential for
sural nerve is presented in Fig. la.
Although amplitude varied somewhat
between preparations, the nerve could
remainviableandreactiveforseveralhours.
One such preparation still responded with
high amplitude to stimulation after being
left in the oil bath at room temperature
(21-50C) overnight (15 h). A similar
preparation, incubated at 36-8°C in the
presence of 10mM MIS, showed no reduc-
tion in either conduction velocity or
amplitude for up to 5 h. The amplitude
for tibial nerve action potential was about
twice that of the sural nerve, whilst the
amplitude of that for median nerve was
intermediate. The temperature coefficient
for conduction velocity was measured
in 10 sural-nerve preparations and found
to be in the range of 0-6-0-85 m/s/0C with
a mean value of 0'7 m/s/°C (Fig. lb). Fig.
lb is illustrative and in this case no at-
tempts at trace-pairing were made. For
the reported determination of tempera-
ture coefficient, careful attention was paid
to trace-pairing, since potential sources
of error can result from baseline shifts.
At temperatures above 40'C both ampli-
tude and conduction velocity diminished.
Reducing the bath temperature after this
point resulted in a conduction-velocity
temperature coefficient of the same mag-
nitude. The descending line was, however,
lower (2-5 m/s) but parallel to the ascend-
ing line.
Early experiments involved the use of
an infra-red heating lamp (Hotspot, Model
250-3, Cheltenham, PA) to maintain the
ambient temperature in the region of the
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Fin.. 1. (a) Typical stural nierve actioll )otelitittl i(esured iin ritro at 3(68 X (30X8 in/Is). (b) P'rofile of
action potentials obtained in Viro for the su;r-al nerve, clealyI emphasizing the effect of temperature
on conlduction velocity. Aleasurements of conluction velocity -weie ma(le between 21 C (right-hanId
traces) and 41°C (left-hanct traces).
oil-coated nerve under stutidy. Since it wi-as
not possible to predict air convection
currents and temperature contduction sur-
rounding the nerve, electrophysiological
recordings were performed in an oil bathl
at constant temperature (36*8°C). The
interval between the surgical removal of
the nerve to McEwan's solution at ambient
temperature and measurement of the
electrical parameters did not exceed 1 5
min. No significant differences were ob-
tained between measurements taken in
situ with careful temperature monitoring
acn(I tenlperat,ure coefficienit adjustmenit,
and those recordled in ouir isolated prepara-
tions at const,ant temperattire. Therefore,
the trauma of surgical removal produced
no significant, effects on t,he paramet,ers
studlied.
Table I anid Fig. 2 present, the results
of the various electrophysiological para-
meters measured in the first experiment.
Although there is some variat,ion in the
det,erminations between times, the varia-
tion is niot, consistent nor statistically
significant betweeni times, nor does it differ
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TABLE I.-Effect of a single i.p. dose of misonidazole at 1 mg/g body weight in male CBA
mice (25 g) under pentobarbital anaesthesia. Electrophysiological parameters measured
in vitro at 36.8°C
Parameter Nerve
Conduction
velocity
(m/sec)
Stimulation
threshold (V)
High-frequency
stimulation
cut off (Hz)
Twin-pulse
delay time
(ms)
Sural
Tibial
Median
Sural
Tibial
Median
Sural
Tibial
Median
Sural
Tibial
Median
Misonidazole-treated
I h 2h 4h 6h
28-8±5-2 (5)
38-3 + 7-2 (5)
20-8±2-6 (4)
0-54±0-08 (5)
1-10 1-3 (4)
0-54 0-08 (4)
1260 + 204 (5)
1330± 84 (5)
1187± 75 (4)
0-46±0-11 (4)
0-44 0-04 (5)
0-43 + 0-05 (4)
34-4 5-2 (4)
39-0+5-1 (4)
26-9+0-87 (3)
0-60 0'24 (4)
0-51 0-34 (3)
0-80 0-43 (4)
1312 85 (4)
1362±25 (4)
1200 + 180 (3)
0-41 + 0-01 (4)
0-45+0-06 (4)
0-43 +0-07 (3)
34-5±2-9 (5)
36-9 4-3 (5)
18-2±2-9 (5)
0-43+0-13 (5)
0-38+0-02 (4)
0-53+0-12 (4)
1420 + 67 (5)
1480+ 141 (5)
1150+ 132 (5)
0-38 + 0-92 (5)
0-41 + 0-06 (5)
0-51 + 0-08 (5)
31-2+3-1 (8)
39-5+ 7-4 (7)
18-7 + 4-6 (6)
1-9+ 1-8 (4)
0-56 + 0-25 (4)
1-1+0-63 (4)
1400 _108 (4)
1400 +58 (4)
1250 + 264 (3)
0 40 + 0-02 (4)
0-44 + 0-04 (4)
0-48 + 0-07 (3)
Saline-
treated
1 h
29-2 3-0 (6)
33-4±4-9 (6)
19-8 + 2-2 (6)
0-54±0-21 (6)
0-35± 0-05 (6)
0-72+0-11 (6)
1408± 92 (6)
1383 + 68 (6)
991±228 (6)
0-38 0-04 (6)
0-38 0-05 (6)
0-58±0-19 (6)
Results are expressed as mean values +s.d. The number of determinations appears in parentheses.
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FIG. 2. Sural nerve conduction velocity,
m/s measured in vitro at 36.80C at different
times after a single i.p. injection of either
misonidazole (1 mg/g body wt, *)
or saline (1 ml per 20 g body wt, 0) in
CBA mice (25 g), and the serum level of
misonidazole after a lmg/g i,p, injection
(dashed line). Error bars represent s.d.
significantly from that of the saline-
treated controls. Conduction velocity for
the median nerve was -'20 m/s, for the
sural nerve 30 m/s, and for the tibial nerve
35 m/s. Threshold values and refractory
time were about the same for all 3 nerves
at 0-5 V and 0-45 ms. The ability of the
sural and tibial nerves to carry high-
frequency stimulation was the same at
1400 Hz, whilst the median nerve was
--.'200 Hz lower.
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FIG. 3.-Effectofi.p.administration ofpheno-
barbital anaesthetic alone (*-*-);
pentobarbital plus 1 ml saline (22°C)
(x --- x); and pentobarbital plus mison-
idazole (1 mg/g body wt in 1 ml saline at
22°C) (M U) onbody-coretemperature
with time. The serum level of misonid-
azole after a 1 mg/g i.p. is plotted as the
dashed line. Error bars indicate s.d.
In an attempttoreconcilethesenegative
findings in all parameters testedwith those
of Hirst et al. (1978) we undertook the
temperature study using the same strain
and sex ofmice. Fig. 3 depicts the changes
in body-core temperature after the admin-
istration of pentobarbital anaesthesia,
anaesthesia and saline, and anaesthesia in
combination with MIS. The anaesthetic
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either alone or in combination with saline
caused a 9TC drop in body-core tempera-
ture within 1 h. At 2 h after administra-
tion, body temperature began to return,
and achieved its normal limits at 4 h. In
contrast, animals that received the anaes-
thetic in combination with the drug
reached their lowest body temperature at
2 h. Thereafter, the return to normal was
delayed, so that after 7 h, body tempera-
ture was still significantly depressed (P<
0.01, Student's t test). Measurements of
serum drug concentration indicate that
a peak serum level of approximately
6 mm was obtained 0 5 h after the i.p.
administration of MIS at 1 mg/g with a
t1- of 1-5 h (Fig. 4). Thus at 7 h after
injection, blood serum concentration was
still 0.35 mm. Although the serum drug
levels were determined in female BALB/
cKa mice after i.p. administration of MIS
at 1 mg/g body wt, there was no significant
difference between the data recorded in
terms of the percent serum concentration
with time and the data reported bythe
Hirst group in male CBA mice.
Since a dramatic reduction in conduc-
tion velocity was reported by Hirst et al.
(1978) 12-2 h after drug administration
underPenthraneanaesthesia. we investiga-
ted the cumulative effect of the drug with
this anaesthetic. As seen in Fig. 5, the
administration of 1 mg/g of MIS alone
produced a 3°C drop in body temperature
within 30 min. This depression was main-
tained for up to 4 h. The administration
of the inhalation anaesthetic further de-
creased body-core temperature by 3°C.
It is to be emphasized that the tempera-
ture in the region ofthe nerves in the drug-
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FIa. 4. Semilog plot of serum drug levels
(mM)writh time (h) in female BALB/cKa
mice (18-22 g) after i.p. administration of
1 mg/g body eit miasonidhazole. Error bars
rep)resent s.d.
treated mice may be significantly lower
than the observed depressions in core
temperature. However, with isolation of
the sural and tibial nerves in the 36m8C
oil bath, no change in conduction velocity
was shown either at 1eh or 4 h after drug
administration, nor for that matter any
difference from the saline-treated controls
(Table II).
The Hirst group used the inhalation
anaesthetic, Penthrane. An attempt was
made to duplicate their experimental
conditions. Since temperature markedly
affectsthe conduction velocity, theambient
temperature in the area of measurement
was maintained by an infra-red lamp. In
spite of this precaution, similar reductions
in nerveconductionvelocity in these insitu
measurements were noted by injection of
TABLE IL.-Effect ofa single i.p. dose ofmisonidazole at 1 mg/g body weight in male CBA
mice (25 g) underPenthrane anaesthesia. Conduction velocity measured in vitro at 36 8°C
Time after (Irug administration
1-5 h 4-0 h
Misonidazole Saline MIisonidazole Saline
:31-1 + 4-8 (5) 34-3 + 2-3 (5) 30-8 + 1-75 (5)
36-5 + 3-6 (5) 37-1 + 4-8 (5) 37-0 + 2-4 (5)
Rlesults are expressed as mean valuies + s.d. The number of determination.s appear.s in parenthesis.
Nerve
Sural
Tibial
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FiG. 5.-Effect of i.p. misonidazole at 22°C to 1 mg/g body wt in unanaesthetized CBA mice (25 g) on body-core temperature at different times after injection (0 0). Penthrane anaesthetic administered at 1-5 or 4 0 h caused a further drop of body-core temperature of <3°C (0- - -O). Ambient temperature, 21°C. Error bars represent s.d. The serum level of misonidazole after an i.p. injection of 1 mg/g body wt is shown as the dashed line.
the solvent vehicle alone at 1 ml/20 g body
wt (see Fig. 6). In addition there was a
shift of the wave forms to those of a later
time presumably owing to changing
bodytemperature despite the maintenance
of the ambient temperature. The overall
error from all sources in any one deter-
mination of conduction velocity with the
methods used in the present study was
estimated to be of the order of 10%. This
is within the accuracy limitations of the
conventional equipment used in this in-
vestigation. The shift of wave-form in
Fig. 6 represents a decrease in conduction
velocity of '.20%.
DISCUSSION
The present investigation demonstrates
that sensory, motor and mixed nerve
bundles can be successfully isolated from a
mouse, maintained in a controlled environ-
ment and temperature, and remain viable
for reasonable periods of time after isola-
tion. The physiological properties of the
nerves do not appear to be markedly
altered by the isolation protocol in vitro,
in which one stimulus point was used,
compared to those measured invivo, where
two stimulus points were used. Hirst et al.
(1978) determined a temperature co-
efficient of 0-89-1-07 m/s/°C in an in vivo
preparation. Although slightly lower, the
in vitro value obtained in this study of
0-6-0-85 m/s/°C is reasonably similar,
and probably not significantly different.
Furthermore, conduction-velocity meas-
urements on untreated mice are also in
agreement. The Hirst group measured
essentially a motor component and ob-
tained a mean value of 29'2 m/s at 25°C.
This value would rise to 41 m/s with the
temperature correction coefficient ob-
tained in their investigation, or 37-4 m/s
with the temperature coefficient obtained
in our investigation. The present motor-
nerve conduction velocity of 35 m/s at
36*80C for the tibial nerve is in good agree-
ment. The slightly lower value is to be
expected since it is based on the delay to
peak height rather than a difference in
baseline defection points.
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FIG. 6.-(a) Typical gastrocnemius muscle response after serial stimulation at 7-8 V. Distance
between stimulation sites No. 1 and No. 2 is 6-5 mm. Trace obtained in situ in Penthrane-
anaesthetized CBA mice. Conduction velocity, 32-5 m/s. Ambient temperature maintained at
31-5°C with an infra-red heat lamp. (b) Effect of i.p. administration of 1 ml saline (22°C) on gastro-
enemius muscle response in situ under conditions specified for a conduction velocity of 26-0 m/s at
0 5 h after injection. Apparent reduction in conduction velocity, 20%. Ambient temperature
maintained at 31-7°C with infra-red lamp. Conduction velocity measured 1-5 h after injection began
to return to normal values typified by trace (a).
This agreement makes it more difficult
to reconcile the differences observed in
drug-treated animals. Relatively little
information is available from the report
by Hirst et al. on the direct handling of
the animals or the effect of the solvent
vehicle alone on nerve-conduction velocity.
Thus we have investigated the magnitude
and time course of the temperature
changes induced by the drug in the pres-
ence and absence of anaesthetic. The
reduction in body-core temperature in-
duced bythe drug alone inunanaesthetized
mice at 1 mg/g body wt was 3°C, which
was established within 30 min and con-
tinued for at least 4 h (see Fig. 5). Pen-
thrane anaesthesia caused a further drop
in body-core temperature. It is pertinent
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to note that the reduction of nerve-con-
duction velocity reported by Hirst et al.
(1978) closely parallels the reduction in
body-core temperature induced by the
drug under pentobarbital anaesthesia.
Consequently the reduction in the conduc-
tion velocity reported by these workers
may not be related to a direct effect ofthe
drug on the nerve. It may be that, in
essence, the Hirst group measured the net
effect of anaesthesia and drug in reducing
body-core temperature. Our findings show
that the drug-induced depression of body-
core temperature is maintained for at
least 2 h after the drug has been effectively
clearedfromthe serum compartment, both
with and without anaesthetic. Since our
nerve preparations were isolated under
strict temperature control, no changes in
conduction were detected after drug
treatment.
One possible criticism of the in vitro
testing system used in the present study
is that it is possible that the drug had been
washed out of the isolated nerve prepara-
tion during the isolation procedure. How-
ever, we were unable to demonstrate any
reduction in conduction velocity after
incubation of such a preparation for 5 h
with 10mM MIS at 36 8°C. It would there-
fore seem unlikely that a single exposure
to the drug either in vitro or in vivo has
resulted in any significant reduction in
the nerve-conduction velocity in the
present study, or that by the Hirst group.
The observed changes in body tempera-
ture induced by MIS reflect changes in
metabolic rates. A related nitroimidazole,
metronidazole, inhibits cellular 02 utiliza-
tion (Biaglow et al., 1974; Durand et al.,
1976) which could be associated with less
energy and heat production. At 06 mg/g
body wt, a decrease in heart rate of
,35% and a decrease in body tempera-
ture of almost 6°C in unanaesthetized
C3H mice has been reported (Haynes &
Inch, 1976). Since heart rate and cardiac
output are strongly coupled to metabolic
rate, Haynes & Inch concluded that the
observed falls in heart rate and rectal
temperature were fairly well correlated.
Although MIS has not been shown mar-
kedly to decrease the 02 consumption
of V79 and Ehrlich carcinoma cells in
vitro at concentrations lower than 1 mM,
either in the presence or absence ofglucose
(Biaglow et al., 1978) a 20% reduction
of 02 utilization by V79 cells has been
reported at a drug concentration of 5 mM
(Durand et al., 1978). Our observations
on the effect ofi.p. administration of MIS
on body-core temperature in the absence
of anaesthetic indicate that the effect of
the drug in vivo may be more complex
than the data obtained in vitro may indi-
cate.
In general, mice have poor temperature
regulation, due mainly to their relatively
large surface/volume ratio (Bernstein,
1966). No significant changes in body
temperature have been reported in cancer
patients treated with MIS. However, a
clinical incidence of peripheral sensory
polyneuropathy has been reported (see
introductory paragraph). One possible
connection between the lack of evident
neurotoxicity in mice after MIS adminis-
tration and the reported neurotoxicity in
human patients may be that, in the mouse,
the physiological response of reduction
of core temperature may protect the ani-
mal against the effect ofthe toxic chemical
species involved in the induction ofneuro-
toxicity.
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